The autonomous organization solving aging
Can we make
death optional?
Aging is not an inevitable decline but a complex biological process that can be observed, measured, and modified. We're pioneering a new approach to longevity research that combines cutting-edge science with decentralized governance and funding mechanisms to redefine the way we think about aging at a foundational level.
Our mission is to extend human healthspan and lifespan through accelerated research, open collaboration, and innovative funding structures that align incentives across the longevity ecosystem.
Engineering a Distributed Intelligence Network

Accelerating advancements in LongBio with purpose-built AI
VitaDAO is transforming longevity research by leveraging AI to radically accelerate the rate at which scientific ideas are generated, validated, and executed. We believe that by combining human expertise with cutting-edge artificial intelligence, we can dramatically accelerate the pace of discovery and translation in aging research.
To truly make death optional, we must implement robust automations and adopt an unbiased approach to scientific research. By removing human error and subjective biases from critical processes, our systems ensure that every research insight is evaluated solely on its merit.
FUNDED PROJECTS

EQUITY
$ 350000
Rubedo.Life - Prodrug Discovery Platform

IP-NFT
$ 91300
ARTAN Bio - Mutation-Specific Codon Suppression for Aging and Longevity

IP-NFT
$ 285000
Discovering Novel Autophagy Activators - Korolchuk Lab
FUNDING IRL
SCIENCE ONCHAIN
31
Projects
Funded
$4.7M
Funding
Deployed
$60.0M
Projects
FDV
3
Target
Discovery
Projects
18
Drug
Discovery
Projects
3
Preclinical
Drug Dev
Projects
3
Clinical
Drug Dev
Projects
8
IPTs
Generated
3
Companies
Founded
FUNDING IRL
SCIENCE – ONCHAIN
31
Projects
Funded
$4.7M
Funding
Deployed
$60.0M
Projects
FDV
3
Target
Discovery
Projects
18
Drug
Discovery
Projects
3
Preclinical
Drug Dev
Projects
3
Clinical
Drug Dev
Projects
8
IPTs
Generated
3
Companies
Founded
OUR VISIONARY PARTNERS
























OUR VISIONARY PARTNERS





